Linscott Walt Addison 4
4 · Intec Pharma Ltd. · Filed Jan 23, 2019
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-22+90,000→ 90,000 totalExercise: $7.63Exp: 2026-01-22→ Ordinary Shares (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through January 22, 2022.